(PharmaNewsWire.Com, May 15, 2021 ) The Trauma Products Market is projected to reach USD 7.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 8.3% during the forecast period. The growth in this market is driven by the rising prevalence of degenerative bone diseases, increasing incidence of sports injuries, and the growing number of road accidents and falls. However, Metal sensitivity in patients with trauma implants has hampered market growth to an extent.
High incidence of trauma injuries, rising geriatric population to drive the demand for trauma products
Based on type, internal fixators held the largest share of the trauma products market in 2019. This is followed by sleep apnea, asthma, and infectious diseases. The large share of the internal fixators segment can be attributed to the high incidence of trauma injuries, rising geriatric population, and the high adoption of internal fixators over external fixators.. This segment is also expected to show the highest growth in the market.
The hospitals segment accounted for the largest market share in 2019
By end user, the trauma products market is segmented into hospitals and trauma centers and ambulatory surgery centers. In 2019, the hospitals and trauma centers segment accounted for the largest share of the global trauma products market. The large share of this segment can be attributed to the growing number of patients undergoing treatments in hospitals, increasing government support to supply well-equipped instruments, and infrastructural developments in hospitals.
North America was the largest regional market for bioanalytical testing services in 2019
The global trauma products market is segmented into four major regions, namely, North America, Europe, the Asia and RoW. In 2019, North America accounted for the largest share of the market. The large share of North America region is mainly attributed to the strong presence of a large number of major manufacturers and large number of trauma procedures performed in North.
Some of the prominent players operating in this market include Acumed LLC (US), Arthrex Inc. (US), B. Braun Melsungen AG (Germany), Citieffe s.r.l. (Italy), CONMED Corporation (US), DePuy Synthes (US), Double Medical Inc. (China), Integra LifeSciences Corporation (US), Orthofix Holdings Inc. (US), Smith & Nephew (UK), Stryker (US), Wright Medical Group N.V. (US), BioPro (US), OsteoMed (US), AGOMED (Germany), NEOORTHO (Brazil), Response Ortho (Turkey), Ortosintese (Brazil), Traumédica (Brazil), and Zimmer Biomet (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
